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ABSTRACT
Pairing of a given E3 ubiquitin ligase with different
E2s allows synthesis of ubiquitin conjugates of
different topologies. While this phenomenon con-
tributes to functional diversity, it remains largely
unknown how a single E3 ubiquitin ligase recog-
nizes multiple E2s, and whether identical structural
requirements determine their respective inter-
actions. The E3 ubiquitin ligase RNF8 that plays
a critically important role in transducing DNA
damage signals, interacts with E2s UBCH8 and
UBC13, and catalyzes both K48- and K63-linked ubi-
quitin chains. Interestingly, we report here that a
single-point mutation (I405A) on the RNF8 polypep-
tide uncouples its ability in catalyzing K48- and
K63-linked ubiquitin chain formation. Accordingly,
while RNF8 interacted with E2s UBCH8 and
UBC13, its I405A mutation selectively disrupted
its functional interaction with UBCH8, and impaired
K48-based poly-ubiquitylation reactions. In
contrast, RNF8 I405A preserved its interaction with
UBC13, synthesized K63-linked ubiquitin chains,
and assembled BRCA1 and 53BP1 at sites of DNA
breaks. Together, our data suggest that RNF8
regulates K48- and K63-linked poly-ubiquitylation
via differential RING-dependent interactions with
its E2s UBCH8 and UBC13, respectively.
INTRODUCTION
Ubiquitylation shares three common enzymatic steps
orchestrated by the concerted actions of ubiquitin
activating enzyme (E1), ubiquitin conjugating enzyme
(E2) and ubiquitin ligase (E3) (1,2). Like many other
post-translational protein modiﬁcation systems, ubiquitin
conjugates serve as molecular switches to regulate and
ﬁne-tune processes that include protein stability and
protein–protein interactions. Accordingly, the complexity
of protein ubiquitylation, illustrated by diverse linkage
patterns and length of poly-ubiquitin chains, determines
the nature and the functional consequences of these
conjugation events.
Ubiquitin is a 76 amino acid polypeptide that harbors
seven lysine (K) residues (K6, K11, K27, K29, K33, K48
and K63). Mono-ubiquitylation involves formation of an
isopeptide bond between a single ubiquitin moiety and a
lysine residue of its target proteins. Via one of the seven
lysine residues on ubiquitin, ubiquitin chains on protein
conjugates can be extended, giving rise to diverse ubiquitin
chain topologies (3,4). Moreover, recent studies also
uncovered formation of linear ubiquitin chains that
involves linkages between N- and C-terminal of ubiquitin
(5). While functions of many of these distinct ubiquitin
chains remain obscure, poly-ubiquitin chains composed
of K48-linkages are generally associated with commitment
for proteasomal degradation, whereas K63-linked
poly-ubiquitylation plays established roles in DNA
damage–repair, protein kinase activation and receptor
endocytosis (6–8).
The Ring Finger Protein RNF8 is an ubiquitin ligase
that belongs to the RING-type subfamily. The RNF8
polypeptide harbors two conserved domains, namely the
phospho-peptide-binding FHA (Forkhead-Associated)
and the E3 ubiquitin ligase signature RING (Really
Interesting New Gene) motif. While the RNF8 FHA
mediates its interaction with the DNA damage mediator
protein MDC1 and allows its relocalization to DNA
damage sites, its C-terminal RING domain has been
shown to recruit the E2 ubiquitin-conjugating enzyme
UBC13 to facilitate the transfer of K63-linked
poly-ubiquitin chains onto H2A-type histones
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Thus, RNF8 contributes to the ubiquitin landscape at
the damage-modiﬁed chromatin to allow productive and
local accumulation of tumor suppressor proteins BRCA1
and 53BP1 (9–12). While the RNF8–UBC13 pair is
pivotal in DNA damage signal transduction, RNF8 has
also been reported to interact with other E2s, including
UBCH8 (13,14). However, exactly how the RNF8–
UBCH8 interaction is regulated and whether this inter-
action contributes to DNA damage–repair and/or other
cellular processes remains elusive.
In this study, we describe a point mutation (I405A) on
the RNF8 RING domain that uncoupled its K63- and
K48-linked ubiquitylating activities. We found that
RNF8 I405A interacted with UBC13 but not UBCH8,
and was selectively compromised in promoting K48-
based ubiquitin linkages.
MATERIALS AND METHODS
Cell cultures and transfection
The 293T and RNF8-deﬁcient MEF cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) with 10%
fetal bovine serum at 37Ci n5 %C O 2. Culture medium
for MEF cells stably expressing various mutants of
epiptope-tagged RNF8 was supplemented with 2mg/ml
puromycin. Cells were transfected with Lipofectamine
2000 (Invitrogen) according to the manufacture’s
protocol.
Antibodies
Antibodies against gH2AX, 53BP1, BRCA1, ub-H2A and
RAD18 were previously described (10). Conjugated ubi-
quitin was detected by anti-FK2 (Upstate Cell Signaling).
Anti-Flag (M2) and anti-actin antibodies were from
Sigma. Anti-myc (9E10) and anti-HA antibodies were
from Covance.
Expression constructs
cDNAs-encoding RNF8, UBC13, MMS2, UBCH8 and
ubiquitin were subcloned into pDONR201 using
Gateway Technology (Invitrogen), and were subsequently
recombined into Gateway compatible destination vectors
according to manufacturer’s protocol. Site-directed muta-
genesis was performed to generate either deletion or point
mutants of RNF8, UBC13, UBCH8 and ubiquitin, and
desired mutations were conﬁrmed by DNA sequencing.
Co-immunoprecipitation and immunoblotting
Cells were harvested and lysed with NETN buffer (20mM
Tris–HCl, pH 8, 100mM NaCl, 1mM EDTA, 0.5%
Nonidet P-40) 24h post-transfection. Protein extracts
were cleared by centrifugation at 13000rpm for 10min
at 4C. A total of 10% of extract was used to detect the
expression of transfected proteins while the remaining
lysates were incubated with streptavidin-conjugated
beads for 4h at 4C with gentle agitation. Beads
were washed twice and boiled in SDS sample buffer
for 10min. Eluted proteins were then fractionated by
SDS–PAGE and electroblotted to Hybond-P membranes
followed by incubation in 5% skim milk for 30min.
Membranes were incubated with primary antibodies at
4C overnight and subsequently incubated with HRP-
conjugated secondary antibodies (Jackson Immuno-
research Laboratories) for 2h. Signals on the membrane
were visualized by enhanced chemiluminescence (Thermo
Fisher Scientiﬁc).
In vivo ubiquitylation assay
Cells were transfected with 2mg ﬂag-tagged RNF8
and myc-ubiquitin expression constructs. Twenty-four
hours post-transfection, cells were incubated with 10mM
MG132 for 4h prior to protein extraction. Immuno-
precipitation of ectopic RNF8 was carried out under
denaturing condition for 4h at 4C. Beads were boiled
in SDS sample buffer and the eluted proteins were
then analyzed by western blotting.
In vitro ubiquitylation assay
Assay was performed with 0.1mg E1 (Boston Biochem),
0.2mg of puriﬁed UBCH8 or UBC13/Mms2, 1mgo f
puriﬁed RNF8 WT, RING and I405A and 5mg of ubi-
quitin (Boston Biochem) in reaction buffer containing
50mM Tris–HCl (pH 7.5), 10mM MgCl2,1 0 m M
dithiothreitol and 1mM ATP. Reaction was carried out
at 37C for 1h and was stopped by boiling with Laemmli
buffer.
Cycloheximide treatment
To determine the stability of various forms of RNF8,
transfected cells were incubated with 50mg/ml of
cycloheximide. Cells were harvested and lysates were
separated by SDS–PAGE to analyze protein expressions
at indicated time points.
Immunoﬂuorescence staining
Cells grown as monolayer on coverslips were exposed to
ionizing radiation. After a 4-h recovery, cells were washed
with PBS and ﬁxed with 3% paraformaldehyde for
15min at room temperature. Subsequently, cells were
permeabilized in 0.5% triton solution for 3min at room
temperature. To detect ubH2A foci, cells were pre-
extracted with triton solution followed by ﬁxation with
paraformaldehyde. Foci were stained by sequential
incubations of primary antibodies and secondary
ﬂuorophore-conjugated antibodies for 1h, respectively.
Nuclei were visualized by staining with DAPI. Finally,
coverslips were mounted and IR-induced foci were
visualized using an Olympus BX51 ﬂuorescence
microscope.
IR sensitivity assay
For the colorimetric proliferation assay, 800 cells
grown on 96-well plate were irradiated with 0, 1, 2 and
5Gy. Cells were allowed to grow for 5 days at 37C. Cell
viability was measured by Cell Proliferation Kit
(XTT) (Roche) according to the manufacture’s manual.
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triplicates.
For the clonogenic survival assay, 4000 cells were grown
on 10cm
2 plates and irradiated with 0 or 5Gy. The
number of colonies was determined by staining with
Coomassie blue after growing for 10 days. Three inde-
pendent experiments were performed each in triplicates.
RESULTS
Generating the RNF8 I405A mutation
The pairing of an E3 ubiquitin ligase with its E2 ubiquitin-
conjugating enzymes allows productive ubiquitylation,
and dictates synthesis of speciﬁc ubiquitin chain
linkages. Indeed, while the DNA damage-responsive E3
ubiquitin ligase RNF8 interacts with E2s UBC13 and
UBCH8, previous studies suggested that RNF8, via
UBC13, synthesizes K63-linked ubiquitin chains at sites
of DNA breaks and is critically important for proper
cellular responses to DNA damage. While it is not
entirely clear how RNF8 selects UBC13 to effect local
ubiquitylation reactions, HERC2 was found to selectively
promote RNF8–UBC13 but not RNF8–UBCH8 complex
formation (13), suggesting possible structural determin-
ants in these HERC2-regulated events. To examine this
idea, we compared the amino acid sequence of RNF8
RING with RING domains derived from BRCA1,
MDM2 and RING1b. Sequence alignment revealed a
number of conserved residues across the different
RINGs. One of these included the RNF8 cysteine
residue (C403), which when mutated, has previously
been shown to perturb the RING structure and comprom-
ise RNF8 ubiquitin ligase activity (14,15). In addition, we
also identiﬁed a conserved hydrophobic isoleucine residue
(I405) which resided within the ﬁrst zinc-chelating motif
(Figure 1). Accordingly, mutating this residue, as in the
case of BRCA1, MDM2 and RING1b, abolished their
interactions with their respective E2s without affecting
the structure of RING domains (16–19). Thus, we
hypothesized that mutation analogous to this isoleucine
within the RNF8 RING domain may compromise its
binding to its E2s and inactivate its E3 ligase activities.
RNF8
I405A cells promotes DNA damage signaling
We generated an RNF8 mutant in which the isoleucine at
position 405 was replaced by alanine (I405A). We assessed
and compared this point mutant with a RNF8 RING
domain deletion mutant in promoting DNA damage
signals since RNF8 plays an established role in mediating
DNA damage-induced histone ubiquitylation and in
assembling tumor suppressors BRCA1 and 53BP1 at
sites of DNA breaks (9–12). To this end, we retrovirally
infected RNF8-deﬁcient MEFs with expression cassettes
encoding wild-type (WT) RNF8 or its various mutants
(FHA, RING and I405A; Supplementary Figure S1).
Consistent with the fact that the RNF8 is targeted to
ionizing radiation-induced foci (IRIF) through its
phospho-peptide-binding FHA domain-dependent inter-
action with MDC1 (9–11), we found that WT RNF8
and its RING mutants (I405A and RING), but not
the RNF8 FHA, localized to IRIF (Figure 2A).
Moreover, while reconstitution of WT RNF8 functionally
restored IR-induced 53BP1 foci, RING- and FHA-
reconstitutions did not (Figure 2A). Interestingly, to our
surprise, cells reconstituted with the RNF8 I405A mutant
supported IR-induced focal accumulation of 53BP1
(Figure 2A), suggesting that I405A does not impair
RNF8 functions in propagating DNA damage ubiquitin
signals.
RNF8 promotes local ubiquitylation events at sites of
DNA breaks (20). To further examine whether the RNF8
I405A mutant is functional in DNA damage signal trans-
duction, we examined DSB-associated ubiquitin conju-
gates employing antibodies that stain conjugated
ubiquitins (FK2) and ubiquitylated H2A molecules
(ub-H2A). Similar to WT RNF8-expressing cells, but
not those reconstituted with the FHA and RING
mutants, RNF8 I405A promoted damage-induced
ub-H2A and FK2 foci formation (Figure 2B).
Additionally, we observed similar numbers of FK2 and
53BP1 IRIFs in RNF8-deﬁcient MEFs expressing either
WT RNF8 or its I405A mutant over a time course of 8h
(Supplementary Figure S2), suggesting that the RING
domain point mutation (i.e. I405A) does not compromise
the RNF8-mediated IR-induced ubiquitylation events at
DNA damage sites.
Figure 1. Generating the RNF8 I405A mutation. Sequence alignment of RING domains of RNF8, BRCA1, MDM2 and RING1b was shown.
Conserved cysteine and isoleucine (asterisked) residues were highlighted in grey.
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subcellular localization of BRCA1 and RAD18. Both of
these E3 ubiquitin ligases have previously been shown to
concentrate at DNA breaks in RNF8-dependent manners
(9–12,21). In line with the possibility that RNF8 I405A
functionally replaced WT RNF8 in DNA damage signal-
ing, both RNF8 and its I405A mutant, but not FHA
and RING, promoted BRCA1 and RAD18 accumula-
tion at IRIF (Figure 2C).
To further examine the ability of WT RNF8 and I405A
in DNA damage–repair, we quantiﬁed MDC1 foci
formation at different time points after challenging these
cells with a recoverable dose of IR (2Gy). MDC1 operates
upstream of the RNF8-dependent ubiquitylation cascade,
Figure 2. RNF8
I405A has an intact DDR pathway. (A–C) immunoﬂorescence staining of Flag epitope-tagged RNF8, 53BP1, FK2, ub-H2A, RAD18,
BRCA1 and gH2AX foci were shown after 4-h recovery from 10Gy IR. (D) RNF8 deﬁcient MEFs reconstituted with RNF8 WT, FHA, RING
and I405A were immunostained with MDC1 antibody at the indicated time points after exposure to 2Gy IR. Cell with MDC1 foci exceeded 10 per
nucleus was counted as positive and 100 cells were scored for each time point. (E) Radiosensitivity of RNF8 deﬁcient MEFs reconstituted with WT,
FHA, RING and I405A of RNF8 was examined 5 days after exposure with various dose of IR by XTT. Error bars represent standard deviations
of the mean from three independent experiments.
Nucleic AcidsResearch, 2012, Vol.40,No. 1 199and its focal accumulation is reﬂective of the cellular
status of DNA damage. Accordingly, while we observed
sustained numbers of MDC1 IRIFs in RING and
FHA-expressing cells, MDC1 foci gradually resolved
in RNF8-deﬁciency cells expressing either the WT or
I405A RNF8 (Figure 2D), indicating that these RNF8
alleles exhibited similar DNA repair dynamics. Together
with the fact that RNF8 I405A conferred cellular resist-
ance to IR to similar extents to its WT counterpart in
RNF8-deﬁcient cells (Figure 2E and Supplementary
Figure S3), we speculated that RNF8 I405A is an active
ubiquitin ligase that is fully functional in promoting
DNA damage-induced ubiquitin signaling.
RNF8
I405A interacts with UBC13 to effect ubiquitylation
Previous studies indicated that RNF8 forms a complex
with the E2 ubiquitin conjugating enzyme UBC13 to
promote local histone ubiquitylation at the damaged chro-
matin, which in turn is critically important for recruitment
and accumulation of a number of checkpoint and repair
proteins (10,12,22). To evaluate if the I405A mutant inter-
acts with UBC13, we performed co-immunoprecipitation
experiments following co-transfection of UBC13 and
RNF8 or its mutants into 293T cells. Reciprocal binding
assays clearly showed that, while the RNF8 RING
failed to interact with UBC13, both WT RNF8 and
I405A physically associated with UBC13 (Figure 3A and
B). Having shown that RNF8 I405A interacts with
UBC13, we next assessed whether I405A is functionally
active as an E3 ubiquitin ligase. Using in vitro
ubiquitylation assays, we found that bacterially puriﬁed
RNF8 proteins (Figure 3C) catalyzed ubiquitylation in
the presence of UBC13/MMS2 (Figure 3D). Consistent
with the fact that RNF8 I405A fully restored RNF8
deﬁciency in DNA damage signal transduction, we
found that RNF8 I405A, but not RING, supported
auto-ubiquitylation in vitro (Figure 3E). We concluded
that the I405A mutation does not abrogate RNF8–
UBC13 functions in transducing the ubiquitin-mediated
DNA damage signals.
Role of proteasome in regulating RNF8 protein stability
Thus far, our data indicated that RNF8 I405A interacted
with UBC13, and functionally substituted WT RNF8 in
promoting local histone ubiquitylation and assembly of
53BP1, RAD18 and BRCA1 at sites of DNA breaks.
Figure 3. RNF8
I405A interacts with UBC13 to effect ubiquitylation. (A) Association between RNF8 and UBC13 was assessed by immunoblotting
RNF8 immunoprecipitates. 293T cells were co-transfected with plasmids-encoding Streptavidin-binding peptide Flag-tagged RNF8 (SFB-RNF8)
or its mutants and myc-UBC13. Protein lysates were incubated with streptavidin-conjugated beads for 4h at 4C. Proteins were then eluted from
beads, separated by SDS–PAGE and analyzed by western blot with indicated antibodies. Whole-cell extract (WCE) represents 10% of total proteins.
(B) 293T cells were co-transfected with plasmids of SFB-UBC13 and ﬂag-RNF8 or its mutants. UBC13 was immunoprecipitated and subjected to
immunoblotting to detect its interaction with RNF8 and its mutants as described in (A). (C) Puriﬁed proteins of WT, RING and I405A of RNF8
were subjected to SDS/PAGE and visualized by staining with Coomassie blue solution. (D) In vitro ubiquitylation reactions were performed in the
presence of WT RNF8 with or without E2 UBC13/MMS2. (E) In vitro ubiquitylation reactions were performed with RING or I405A of RNF8.
Ability of RNF8 or its mutants to form polyubiquitin chain was examined by immunoblotting with FK2 antibody.
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IRIFs were much more readily detected than those of
WT RNF8 (Figure 2A). This prompted us to ask if the
RNF8 proteins may be actively and negatively regulated
by the proteasome. To test this hypothesis, we inhibited
the proteasome using MG132 and analyzed RNF8 IRIFs.
Pre-treatment of MG132 was previously shown to inhibit
53BP1 IRIF by depleting the free ubiquitin pools in
nucleus (11,23). To avoid this indirect effect of proteasome
inhibition, we treated cells with low doses of MG132 only
after IR challenge. Accordingly, addition of MG132
signiﬁcantly increased the number and intensity of WT
RNF8 foci (Figure 4A), suggesting that WT RNF8
proteins may be further stabilized at DNA breaks upon
proteasome inhibition, and that RNF8 proteins may be
regulated by proteasomal degradation. Importantly,
53BP1 IRIF was readily observed in the same MG132-
treated cells, suggesting that the increased WT RNF8
foci formation is, to a large extent, due to inhibition of
proteasomal degradation of RNF8 (Figure 4A).
Mutation at I405A impairs K48 poly-ubiquitylation and
stabilizes RNF8
Our observation that RNF8 is negatively regulated by the
proteasome suggested that the E3 ubiquitin ligase may be
subjected to K48-linked poly-ubiquitylation in vivo.
Indeed, we found that ubiquitylated species of RNF8
can be readily detected in the presence of MG132
(Figure 4B) (14). Moreover, these autoubiquitylation
events were largely dependent on the RNF8 RING, as
ubiquitylated species of RNF8 RING were substantially
reduced (Figure 4C). Consistent with the fact that RNF8
I405A interacted with UBC13 and promoted ubiquitin
conjugations at sites of DNA breaks, we found that
RNF8 I405A was proﬁcient in catalyzing ubiquitin chain
Figure 4. Role of proteasome in regulating RNF8 protein stability. (A) Immunoﬂorescence staining of Flag epitope-tagged RNF8 and 53BP1 foci
were shown 6h following irradiation of 10Gy either in the presence or absence of 1mM MG132. (B) 293T cells were co-transfected with SFB-RNF8
and myc-ubiquitin (Myc-Ub). Twenty-four hours post-transfection, cells were incubated with or without 10mM MG132 for 4h prior to protein
extraction. Lysates were immunoprecipitated for 4h at 4C and eluted with SDS sample buffer. The ubiquitylation status of RNF8 was analyzed by
immunoblotting with indicated antibodies. (C) 293T cells were co-transfected with SFB-RNF8 or its mutants and myc-ubiquitin. Cells were treated
with MG132 for 4h prior to protein extraction. Ubiquitylation of RNF8 and its mutants was assessed by immunoprecipitation and immunoblotting
as described in (B). (D) Synthesis of ubiquitin chains by RNF8 and its mutants was assessed. 293T cells were co-transfected with SFB-RNF8 or its
mutants and WT ubiquitin or ubiquitin K48- and K63-only mutants.
Nucleic AcidsResearch, 2012, Vol.40,No. 1 201formation in the substrate-independent ubiquitylation
assay (Figure 4C).
Prompted by the considerable difference of IRIF
between WT RNF8 and I405A mutant, we speculated
that RNF8 I405A might differ from RNF8 in its ability
in catalyzing K48-linked ubiquitin chains. To test this, we
transfected 293T cells with expression constructs of RNF8
or its mutants, together with either wild-type ubiquitin or
its single lysine-containing mutants (i.e. K48 or K63 only).
In contrast to RNF8 RING, WT RNF8 became heavily
modiﬁed not only by wild-type ubiquitin, but also by
ubiquitin chains composed primarily of K48- or
K63-ubiquitin linkages (Figure 4D). Consistent with our
observation that RNF8 I405A preserved its interaction
with the K63-ubiqutin chain promoting E2 UBC13,
RNF8 I405A was post-translationally modiﬁed by
K63-ubiquitin chains. Surprisingly, RNF8 I405A was
speciﬁcally compromised in promoting K48-based
ubiquitin chains (Figure 4D).
To further substantiate the notion that the RNF8 I405A
mutation may selectively disrupt the RNF8-dependnent
K48-ubiquitin chain promoting activity, we performed
co-immunoprecipitation assays to examine the binding
of various forms of RNF8 with its cognate E2 UBCH8,
which is responsible for K48-ubqiuitin chains formation
and has been associated with proteasomal degradation
(14,24). Indeed, results obtained from reciprocal binding
assays demonstrated that only WT RNF8, but neither
RING nor I405A, associated with UBCH8 (Figure 5A
and B). Consistently, WT RNF8, but not RING and
I405A, promoted UBCH8-mediated ubiquitylation
in vitro (Figure 5C). Together, our results support the
idea that RNF8 interacts with UBCH8 and promotes
K48-based poly-ubiquitylation, which is impaired in
both the RNF8 RING and I405A mutants.
Based on the observation that the RNF8 I405A
mutation inhibited K48-ubiquitin chain formation, we
asked if the RNF8 I405A mutation may promote protein
stability. Upon cycloheximide treatment, we found that
expression of WT RNF8 and its FHA mutant declined
rapidly (Figure 5D), whereas the RNF8 RING and
I405A proteins exhibited enhanced stabilities.
Roles of UBCH8 and UBC13 in RNF8-dependent
ubiquitin conjugation
Next, we assessed the requirement for UBC13 and UBCH8
in promoting the RNF8-mediated K63- and K48-based
ubiquitylation in vivo. We ﬁrst examined roles of UBC13
and UBCH8 in catalyzing RNF8 autoubiquitylation.
Consistently, we found that wild-type UBC13, but not its
catalytically inactive C87A mutant, mediated K63-based
poly-ubiquitylation (Figure 6A). Conversely, UBCH8,
but not its C139A mutant, promoted ubiquitin chains
composed primarily of K48-linkages (Figure 6B).
Given the possibility that the RNF8–UBCH8
interaction may regulate RNF8 protein turnover via
Figure 5. The RNF8 I405A mutation impaired its interaction with UBCH8. (A) 293T cells were co-transfected with plasmids encoding SFB-RNF8
or its mutants and myc-UBCH8. (B) 293T cells were co-transfected with SFB-UBCH8 and ﬂag-RNF8 or its mutants. Interaction was detected by
co-immunoprecipitation and immunoblotting. (C) In vitro ubiquitylation assay was performed with WT, RING and I405A of RNF8 in the
presence of puriﬁed UBCH8 proteins. Reaction mixtures were incubated at 37C for 3h, separated by SDS–PAGE and immunoblotted with
indicated antibodies. (D) 293T cells were transfected with ﬂag-RNF8 and its mutants. Cells were collected at the indicated time points following
the addition of cycloheximide and protein lysates were subjected to immunoblotting to assess expression levels of RNF8 proteins.
202 Nucleic Acids Research, 2012,Vol. 40,No. 1K48-based poly-ubiquitin chains, we further assessed
RNF8 stability in the presence of overexpressed
UBCH8. Accordingly, using UBC13 as control, we
found that UBCH8 expression downregulated RNF8
protein levels (Figure 6C). Conversely, UBCH8 depletion
stabilized RNF8 proteins in HeLa cells (Supplementary
Figure S4A and S4B). Together, these data support
our observation that the RNF8–UBCH8 module is
important in catalyzing ubiquitin chains composed of
K48 chains.
While RNF8 I405A interacted with UBC13, promoted
DNA break-associated ubiquitylation, and assembled
DNA repair proteins at sites of DNA breaks, this RING
domain point mutation (I405A) abrogated the interaction
of RNF8 and UBCH8, which in turn resulted in
compromised ability in promoting K48-based poly-
ubiquitylation reactions. Consistent with the pivotal
roles of K63-based ubiquitin conjugates in DNA
damage signal transduction, we found that UBCH8
depletion did not noticeably affect RNF8 functions
in promoting FK2 and 53BP1 IRIF formation
(Supplementary Figure S4C), suggesting that the RNF8–
UBCH8-catalyzed ubiquitin conjugates composed of K48
chains are not required for the assembly of DNA repair
factors at the damaged chromatin.
DISCUSSION
In this study, we have described a novel intrinsic property
of a RING domain that enables differential synthesis
of ubiquitin chains composed of distinct linkages. We
found that a subtle point mutation on the DNA
damage-responsive E3 ubiquitin ligase RNF8 uncoupled
its K48- from its K63-linked ubiquitin chain promoting
activities. This was accomplished, in part, via regulation
of RNF8 RING-dependent interactions with E2s UBCH8
and UBC13 (Figure 7).
Mutating the conserved isoleucine residue that reside
within the zinc-binding loop of RING domain-containing
E3 ubiquitin ligases, including MDM2 (I440A), BRCA1
(I26A) and RING1b (I53A), altered their hydrophobic
binding surface, and disrupted interactions with their
respective E2s (16–19). Built upon our previous work
that implicated important roles of electrostatic contribu-
tion in selective E3–E2 pairing (25), we found that the
RNF8 bearing an I405A mutation on its RING
domain selectively perturbed its interaction with UBCH8
and abrogated K48-linked ubiquitylation activities.
Interestingly, the RNF8 I405A mutation did not com-
pletely abolish its ubiquitin ligase activity. Rather,
RNF8 I405A interacted with the E2 ubiquitin conjugating
enzyme UBC13 and promoted K63-linked ubiquitin
chains. The functionality of the RNF8 I405A–UBC13
interaction is underscored by its ability in catalyzing
DNA break-associated ubiquitylation events, which is in
turn allowed proper assembly of tumor suppressors 53BP1
and BRCA1 at IRIF and promoted cellular survival in
response to IR. The fact that the I405A mutation, which
is intrinsic to RNF8, speciﬁcally disrupted its interaction
with UBCH8 but not UBC13 raises the possibility that
Figure 6. Roles of UBC13 and UBCH8 in RNF8-mediated poly-ubiquitylation. (A) 293T cells were transfected with SFB-RNF8, WT UBC13 or its
mutant (C87A) and ubiquitin mutants (K48 or K63). Cells were treated with MG132 for 4h before protein extraction. Protein lysates were subjected
to immunoprecipitation for 4h at 4C. Ubiquitylation status of RNF8 was determined by immunoblotting with indicated antibodies. (B) 293T cells
were transfected with SFB-RNF8, WT UBCH8 or its mutant (C139A) and ubiquitin mutants (K48 or K63). Ubiquitylation of RNF8 was
determined as described in (A). (C) 293T cells were co-transfected with ﬂag-RNF8 and myc-UBCH8 or myc-UBC13. Cells were incubated with
or without cycloheximide and expression of RNF8 was analyzed by immunoblotting (left). Ectopic expression of myc-UBCH8 and -UBC13 were
shown by immunoblotting (right).
Nucleic AcidsResearch, 2012, Vol.40,No. 1 203pairing of RNF8–E2s may be subjected to stringent
regulation in vivo. In line with this possibility, a previous
report identiﬁed HERC2 as a scaffold protein that
promoted DNA damage ubiquitin signaling by enhancing
the RNF8–UBC13 association (13). Inactivation of
HERC2 weakened the RNF8–UBC13 interaction, and
on the other hand, enhanced RNF8 binding to UBCH8
(13). Thus, although it remains unknown mechanistically
how HERC2 regulates speciﬁc pairing of RNF8 and its
E2s, it is tempting to speculate that HERC2, via its
binding to RNF8, may alter the RNF8 RING to favor
binding to UBC13 but not UBCH8. Further experiments
will be needed to address this possibility.
A scenario is now emerging in which the damage-
modiﬁed chromatin is decorated by a plethora of ubiquitin
conjugates, each of which may serve speciﬁc functions.
In concert, these post-translational modiﬁers coordinate
cell proliferation and DNA repair, and promote optimal
cell survival in response to genotoxic stress (9,26). While
RNF8 functions involving UBC13-dependent K63-linked
ubiquitin chains play important roles in assembling check-
point and repair proteins at sites of DNA breaks, we did
not observe a requirement for UBCH8 in these events (9)
(Supplementary Figure S4C), suggesting that the RNF8–
UBCH8 module may regulate yet-to-be identiﬁed cellular
processes. Apart from mediating histone ubiquitylation
events at DNA damage sites, previous studies indicated
that RNF8 regulates mitotic exit (27,28). Thus, it will be
of signiﬁcant interest to test whether the RNF8-dependent
K48-ubiquitin chains may be important in this regard.
Our observations that the subtle point mutation on the
RNF8 polypeptide selectively compromised K48- but
not K63-ubiquitin chain promoting activities provide a
strategic means to speciﬁcally dissect RNF8–UBCH8
functions in vivo.
Interestingly, while we found that RNF8 RING domain
mutants (i.e. I405A and RING) displayed enhanced
stability when compared to wild-type proteins, turnover
of these RING mutants nevertheless was substantial
(Figure 5D). We suspect that RNF8 may also be
targeted by other E3 ubiquitin ligases. Further experi-
ments will be needed to address this possibility.
In conclusion, we have provided novel insight of
how RNF8 may differentially mediate K48- and
Figure 7. Differential functions of RNF8 E3 ubiquitin ligase activity. RNF8, via UBC13, catalyzes K63-linked poly-ubiquitylation at DSBs.
Ubiquitylated H2A and H2AX are pivotal in assembling downstream DNA damage response proteins including 53BP1 and BRCA1. RNF8 also
interacts with UBCH8 to synthesize K48-linked ubiquitin chains. This may occur on RNF8 itself, allowing the E3 ubiquitin ligase to regulate its own
abundance in cells, and/or may involve other unknown substrates.
204 Nucleic Acids Research, 2012,Vol. 40,No. 1K63-poly-ubiquitylation, and have illustrated the versatil-
ity of speciﬁc E3–E2 pairings in regulating different types
of poly-ubiquitin chains. Given that any given E3 ubiqui-
tin ligase may interact with multiple E2s, with each
devoted to speciﬁc cellular functions, our identiﬁcation
of RNF8 I405A with selective inactivation of K48- but
not K63-ubiquitin chain promoting activity also highlights
potential methodologies via which to study deﬁned
functions involving distinct ubiquitin chain topologies.
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